Cargando…

Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice

PURPOSE: Using proteomics to study the effect of semaglutide on cardiac protein expression in obese mice. Assessment of the effect of semaglutide on cardiac function in obese mice. MATERIALS AND METHODS: The mice were randomly divided into three groups: the control group (WC), the high-fat group (WF...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Xiaoyu, Yue, Lin, Ban, Jiangli, Ren, Lin, Chen, Shuchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704011/
https://www.ncbi.nlm.nih.gov/pubmed/36452054
http://dx.doi.org/10.2147/JIR.S391859
_version_ 1784839971182477312
author Pan, Xiaoyu
Yue, Lin
Ban, Jiangli
Ren, Lin
Chen, Shuchun
author_facet Pan, Xiaoyu
Yue, Lin
Ban, Jiangli
Ren, Lin
Chen, Shuchun
author_sort Pan, Xiaoyu
collection PubMed
description PURPOSE: Using proteomics to study the effect of semaglutide on cardiac protein expression in obese mice. Assessment of the effect of semaglutide on cardiac function in obese mice. MATERIALS AND METHODS: The mice were randomly divided into three groups: the control group (WC), the high-fat group (WF), and the high-fat diet with semaglutide intervention group (WS). Serum samples were collected, and lipids, blood glucose, inflammatory and oxidative stress markers, and cardiac ultrasound, were examined. The cardiac weight of each group of mice was measured, and pathological alterations were examined. Inflammation and oxidative stress levels in heart tissue were evaluated. The labeling coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS) platform was used to find differentially expressed proteins (DEPs) and screen for related pathways and key proteins in a proteomics study. RESULTS: Semaglutide greatly alleviated obesity-induced lipid metabolism abnormalities, improved cardiac ventricular wall thickening, and significantly reduced myocardial collagen content in obese mice. Semaglutide significantly reduces obesity-induced inflammation and oxidative stress. There were 64 DEPs in the WF/WC group, with 39 upregulated proteins and 25 downregulated proteins. The WS/WC group, on the other hand, had 83 DEPs, including 57 upregulated and 26 downregulated proteins. Following functional analysis, DEPs were shown to be largely associated with lipid metabolism and peroxisomes. Apolipoprotein A-II, catalase, diazepam-binding inhibitor, paraoxonase-1, and hydroxysteroid 17-dehydrogenase-4 were all upregulated in the WF group but significantly downregulated in the WS group. A high-fat diet increases the expression of lipid synthesis and transport proteins while increasing inflammation and oxidative stress damage. CONCLUSION: Semaglutide decreases lipid synthesis alleviates inflammation and oxidative stress and prevents lipid peroxidation and cardiac impairment.
format Online
Article
Text
id pubmed-9704011
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97040112022-11-29 Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice Pan, Xiaoyu Yue, Lin Ban, Jiangli Ren, Lin Chen, Shuchun J Inflamm Res Original Research PURPOSE: Using proteomics to study the effect of semaglutide on cardiac protein expression in obese mice. Assessment of the effect of semaglutide on cardiac function in obese mice. MATERIALS AND METHODS: The mice were randomly divided into three groups: the control group (WC), the high-fat group (WF), and the high-fat diet with semaglutide intervention group (WS). Serum samples were collected, and lipids, blood glucose, inflammatory and oxidative stress markers, and cardiac ultrasound, were examined. The cardiac weight of each group of mice was measured, and pathological alterations were examined. Inflammation and oxidative stress levels in heart tissue were evaluated. The labeling coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS) platform was used to find differentially expressed proteins (DEPs) and screen for related pathways and key proteins in a proteomics study. RESULTS: Semaglutide greatly alleviated obesity-induced lipid metabolism abnormalities, improved cardiac ventricular wall thickening, and significantly reduced myocardial collagen content in obese mice. Semaglutide significantly reduces obesity-induced inflammation and oxidative stress. There were 64 DEPs in the WF/WC group, with 39 upregulated proteins and 25 downregulated proteins. The WS/WC group, on the other hand, had 83 DEPs, including 57 upregulated and 26 downregulated proteins. Following functional analysis, DEPs were shown to be largely associated with lipid metabolism and peroxisomes. Apolipoprotein A-II, catalase, diazepam-binding inhibitor, paraoxonase-1, and hydroxysteroid 17-dehydrogenase-4 were all upregulated in the WF group but significantly downregulated in the WS group. A high-fat diet increases the expression of lipid synthesis and transport proteins while increasing inflammation and oxidative stress damage. CONCLUSION: Semaglutide decreases lipid synthesis alleviates inflammation and oxidative stress and prevents lipid peroxidation and cardiac impairment. Dove 2022-11-24 /pmc/articles/PMC9704011/ /pubmed/36452054 http://dx.doi.org/10.2147/JIR.S391859 Text en © 2022 Pan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Pan, Xiaoyu
Yue, Lin
Ban, Jiangli
Ren, Lin
Chen, Shuchun
Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
title Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
title_full Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
title_fullStr Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
title_full_unstemmed Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
title_short Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
title_sort effects of semaglutide on cardiac protein expression and cardiac function of obese mice
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704011/
https://www.ncbi.nlm.nih.gov/pubmed/36452054
http://dx.doi.org/10.2147/JIR.S391859
work_keys_str_mv AT panxiaoyu effectsofsemaglutideoncardiacproteinexpressionandcardiacfunctionofobesemice
AT yuelin effectsofsemaglutideoncardiacproteinexpressionandcardiacfunctionofobesemice
AT banjiangli effectsofsemaglutideoncardiacproteinexpressionandcardiacfunctionofobesemice
AT renlin effectsofsemaglutideoncardiacproteinexpressionandcardiacfunctionofobesemice
AT chenshuchun effectsofsemaglutideoncardiacproteinexpressionandcardiacfunctionofobesemice